Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
A combination of echocardiography, cardiac magnetic resonance, and myocardial perfusion imaging provides the highest accuracy for detecting heart injury in heat stroke patients.
Current evidence does not show a clear link between metabolic syndrome and higher restenosis risk after PCI, though related factors like insulin resistance may play a role.
A nerve block (PIFB) alone did not significantly reduce overall chronic pain after off-pump CABG, but it helped with acute pain and reduced moderate-to-severe chronic pain.
Yes, high GDF-15 levels in the blood are strongly linked to a higher risk of death in acute heart failure patients, with a meta-analysis showing nearly three times the risk.
Yes, heart disease was the second leading cause of death in the US in 2021, ranking behind only COVID-19.
Sepsis-induced cardiomyopathy is caused by inflammation, mitochondrial damage, and calcium handling problems. New treatments include repurposed drugs, traditional Chinese…
There is no confirmed safety data for ifetroban in boys with Duchenne muscular dystrophy and cardiomyopathy because the relevant Phase 2 trial has not yet published safety results.
Yes, LGE-CMR positivity is linked to a higher risk of sudden cardiac death in cardiomyopathy patients, especially those with non-ischemic cardiomyopathy.
Adults with sickle cell disease show three main echocardiographic profiles: high cardiac output with enlarged chambers, mild remodeling with higher pulmonary pressure, or…
Yes, switching to an integrase inhibitor may raise the risk of major adverse cardiovascular events, especially in people with low-to-moderate baseline risk, according to a 2024…
Yes, plasma proteins like NT-proBNP, GDF-15, FGF-23, ADM, and NCAM1 are linked to dilated cardiomyopathy severity in certain gene carriers, particularly those with TTN or MYBPC3…
Genetic variants in TTN and TNNT2, plus CMR traits like ventricular dilation and impaired strain, are potential treatment targets for DCM.
Yes, VISTAQ, a visual standardized method, helps doctors see and quantify heart scarring (LGE) in HCM with excellent reproducibility, without needing complex software.
Yes, spironolactone may lower your risk of heart problems if you have a large heart, especially reducing heart failure hospitalizations and cardiovascular death.
Yes, both GLP-1 receptor agonists and SGLT2 inhibitors reduce hospital visits for heart failure with preserved ejection fraction (HFpEF), according to a large network…
Crestor (rosuvastatin) lowers cardiovascular risk by reducing LDL cholesterol and inflammation, as shown in clinical trials and real-world studies.
Yes, SGLT-2 inhibitors reduce the risk of first heart failure hospitalization in patients with acute coronary syndrome, according to a 2024 meta-analysis.
Yes, the type of myocardial injury matters: type 1 MI carries the highest risk of future heart events, but type 2 MI and acute/chronic myocardial injury also increase risk…
For patients with normal heart function after MI, beta-blockers do not appear to reduce the risk of death or recurrent heart attack based on recent large trials.
AI tools can match or slightly outperform doctors in predicting heart attack biomarkers, but most studies lack real-world validation.
Yes, macrophage signatures are emerging as tools to predict atherosclerosis risk, but they are not yet ready for routine clinical use.
Yes, higher levels of TNF pathway proteins in your blood are linked to increased atherosclerosis and stroke risk, independent of other risk factors.
Yes, SGLT2 inhibitors may reduce the chance of atrial arrhythmia returning after catheter ablation, especially in patients with heart failure.
Yes, schizophrenia is linked to a higher resting heart rate and increased risk of heart rhythm problems, according to a large meta-analysis.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.